Healthcare Services Sector Update – April 2021 M&A Advisory

or to bookmark this page

Click here to bookmark this page

Click here to remove bookmark

The S&P Healthcare Services Index increased by 2.7% over the last month, compared to the S&P 500 Index, which increased 4.0% over the same period.

Over the past month:

  • The sectors that experienced the most growth were Contract Research Organization (up 18.0%), Consumer Directed Health/Wellness (up 12.5%) and Behavioral Health (up 12.1%).
  • The sectors that experienced the largest decline were Home Medical Equipment (down 8.3%), Skilled Nursing (down 7.8%) and Telemedicine (down 2.3%).
  • The current average Last Twelve Months (LTM) revenue and LTM EBITDA multiples for the healthcare services industry overall are 3.71x and 14.8x, respectively.

Healthcare Services Sector Update – April 2021

The sectors with the highest valuation multiples include:

  • HCIT (5.26x LTM revenue, 27.5x LTM EBITDA)
  • Home Health/Hospice (3.11x LTM revenue, 25.0x LTM EBITDA)
  • Contract Research Organizations (4.10x LTM revenue, 24.3x LTM EBITDA)
  • Consumer Directed Health/Wellness (4.46x LTM revenue, 21.9x LTM EBITDA)
Healthcare Services Sector Update – April 2021 2021-05-20T00:00:00.0000000 /insights/publications/m-and-a/healthcare-services-sector-update-april-2021 /-/media/assets/images/publications/featured-images/2020/healthcare-services-sector-november-2020.jpg publication {DC6234F2-03B5-4F3D-9CDE-146A80B170AD} {4DACD310-421A-42AC-BEF4-8AA7E70484CD}

Other Areas We Can Help

M&A Advisory

Middle-market M&A advisory differentiated by industry expertise and superior execution.

M&A Advisory

Insights

M&A Advisory

Healthcare Services Sector Update – May 2021

M&A Advisory
M&A Advisory

Global Software Sector Update – Spring 2021

M&A Advisory
M&A Advisory

Healthcare Services Sector Update – March 2021

M&A Advisory
M&A Advisory

European Chemicals Update – Q1 2021

M&A Advisory